[go: up one dir, main page]

IL139464A0 - Synthetic peptide vaccines for foot-and mouth disease - Google Patents

Synthetic peptide vaccines for foot-and mouth disease

Info

Publication number
IL139464A0
IL139464A0 IL13946499A IL13946499A IL139464A0 IL 139464 A0 IL139464 A0 IL 139464A0 IL 13946499 A IL13946499 A IL 13946499A IL 13946499 A IL13946499 A IL 13946499A IL 139464 A0 IL139464 A0 IL 139464A0
Authority
IL
Israel
Prior art keywords
foot
synthetic peptide
mouth disease
peptide vaccines
vaccines
Prior art date
Application number
IL13946499A
Other languages
English (en)
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22280576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL139464(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of IL139464A0 publication Critical patent/IL139464A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL13946499A 1998-06-20 1999-06-21 Synthetic peptide vaccines for foot-and mouth disease IL139464A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/100,600 US6107021A (en) 1998-06-20 1998-06-20 Synthetic peptide vaccines for foot-and-mouth disease
PCT/US1999/013921 WO1999066954A1 (en) 1998-06-20 1999-06-21 Synthetic peptide vaccines for foot-and-mouth disease

Publications (1)

Publication Number Publication Date
IL139464A0 true IL139464A0 (en) 2001-11-25

Family

ID=22280576

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13946499A IL139464A0 (en) 1998-06-20 1999-06-21 Synthetic peptide vaccines for foot-and mouth disease

Country Status (12)

Country Link
US (1) US6107021A (pt)
EP (1) EP1089759B1 (pt)
JP (1) JP2002518461A (pt)
KR (1) KR100602553B1 (pt)
CN (4) CN101386641B (pt)
AR (1) AR019152A1 (pt)
AU (1) AU754939B2 (pt)
BR (1) BRPI9912178B1 (pt)
CA (1) CA2330178C (pt)
IL (1) IL139464A0 (pt)
TW (1) TWI232108B (pt)
WO (1) WO1999066954A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI229679B (en) * 1998-06-20 2005-03-21 United Biomedical Inc Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
JP3620696B2 (ja) * 1998-09-07 2005-02-16 泰久 福井 ホスファチジルイノシトール−3,4,5−三リン酸を認識するモノクローナル抗体
EP1248642A4 (en) * 2000-01-18 2005-05-18 Ludwig Inst Cancer Res PEPTIDOMIMETIC INHIBITOR OF VEGF-D / VEGF-C / VEGF
JP2005516897A (ja) * 2001-11-07 2005-06-09 イネックス ファーマシューティカルズ コーポレイション 改善された粘膜のワクチン及びその使用方法
US8088388B2 (en) * 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
US20040013649A1 (en) * 2002-05-10 2004-01-22 Inex Pharmaceuticals Corporation Cancer vaccines and methods of using the same
EP1543039B1 (en) 2002-08-12 2011-07-13 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes
KR100531760B1 (ko) * 2003-04-28 2005-11-29 대한민국(관리부서 : 농림부 국립수의과학검역원) 구제역 바이러스의 감염여부를 진단하는 방법 및 이를구현하기 위한 진단키트
CN1290579C (zh) * 2003-10-15 2006-12-20 北京迪威华宇生物技术有限公司 重组口蹄疫病毒vp1融合蛋白疫苗
CN1318592C (zh) * 2003-11-11 2007-05-30 中国农业科学院兰州兽医研究所 O型口蹄疫病毒dna疫苗及其制备方法
CN101448517A (zh) 2005-04-19 2009-06-03 伊莱利利公司 用于疾病免疫干预的单价和多价合成多糖抗原
ES2319483B1 (es) * 2006-08-02 2010-02-10 Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria Construccion peptidica dendrimerica para la prevencion de la fiebre aftosa en animales.
CN101659696B (zh) * 2008-08-27 2013-03-13 中牧实业股份有限公司 亚洲一型口蹄疫合成肽疫苗
CN101659695B (zh) * 2008-08-27 2012-08-29 中牧实业股份有限公司 O型口蹄疫合成肽疫苗
FR2945290A1 (fr) * 2009-05-07 2010-11-12 Maan Zrein Anticorps biomarqueur et dispositif de diagnostic pour la detection de certaines maladies auto-immunes
CN101579522B (zh) * 2009-05-12 2012-09-12 陶钰 一种新型畜用肽苗及其制备方法
CN101643500B (zh) * 2009-05-19 2012-06-06 中牧实业股份有限公司 一种亚洲一型口蹄疫合成肽疫苗
CN101565457B (zh) * 2009-06-04 2014-04-02 中牧实业股份有限公司 一种合成肽疫苗及其制备方法
CN101565458B (zh) * 2009-06-04 2014-01-08 中牧实业股份有限公司 一种动物用肽疫苗及其制备
IN2012DN03928A (pt) 2009-11-02 2015-09-04 Univ Pennsylvania
CN102274496B (zh) * 2010-06-12 2015-05-06 吴晓琰 一种O/Asia I型口蹄疫病毒两价基因工程多肽疫苗及制备方法和用途
US8765141B2 (en) * 2010-07-01 2014-07-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
KR101675185B1 (ko) 2010-07-08 2016-11-10 유나이티드 바이오메디칼 인크. 디자이너(designer) 펩티드-기반 pcv2 백신
CN102175852A (zh) * 2011-01-06 2011-09-07 云南省畜牧兽医科学院 一种口蹄疫固相竞争elisa检测方法
AU2012394394A1 (en) 2012-11-16 2015-06-04 United Biomedical, Inc. Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)
KR20210088754A (ko) 2013-03-15 2021-07-14 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 구제역 바이러스 (fmdv) 공통 단백질, 그에 대한 코딩 서열 및 그로부터 제조된 백신
CN104961808B (zh) * 2013-03-25 2018-09-04 中国牧工商(集团)总公司 用于制备牛口蹄疫o型肽疫苗的多肽及其制备方法和用途
CN103848902B (zh) * 2014-03-07 2016-07-13 中牧实业股份有限公司 一种合成肽疫苗及其制备方法
CN105418738B (zh) * 2015-07-03 2019-04-19 申联生物医药(上海)有限公司 口蹄疫病毒a型抗原多肽、融合抗原多肽及疫苗
CN104961809B (zh) * 2015-07-10 2018-06-26 中牧实业股份有限公司 牛口蹄疫o型结构蛋白vp1抗体酶联免疫检测试剂盒
TWI760322B (zh) * 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
CN106226519A (zh) * 2016-07-18 2016-12-14 洛阳现代生物技术研究院有限公司 一种o型口蹄疫病毒抗体化学发光检测试剂盒
WO2018066948A2 (ko) * 2016-10-05 2018-04-12 서울대학교산학협력단 다수의 에피토프로 구성된 재조합 항원 단백질 및 이의 제조방법
CN107365367A (zh) * 2017-08-16 2017-11-21 山东省农业科学院奶牛研究中心 A型口蹄疫病毒vp1蛋白抗原表位基因多肽及其应用
CN109232720B (zh) * 2018-09-13 2021-11-23 中国农业科学院兰州兽医研究所 一种口蹄疫O型病毒sIgA抗体ELISA检测试剂盒及其应用
BR112021011938A2 (pt) * 2018-12-19 2021-11-09 United Biomedical Inc Epítopos de célula t helper promíscuos artificiais como imunoestimuladores para imunógenos peptídicos sintéticos
KR102451412B1 (ko) 2019-06-18 2022-10-11 대한민국 세포성, 체액성 면역 반응의 동시 유도 및 광범위한 방어능을 갖는 신규 면역 증강용 단백질 및 이를 포함하는 구제역 백신 조성물
KR102672787B1 (ko) * 2019-06-28 2024-06-05 (주)플럼라인생명과학 구제역 바이러스 백신 조성물
CN111803626A (zh) * 2020-07-08 2020-10-23 申联生物医药(上海)股份有限公司 猪口蹄疫o型和a型二价合成肽疫苗及其制备方法与应用
CN111978380A (zh) * 2020-09-02 2020-11-24 天康生物股份有限公司 野生型气肿疽梭菌细胞毒素a及其制备方法、应用和疫苗
CN113061587B (zh) * 2021-04-30 2023-03-31 中国农业科学院兰州兽医研究所 一种抗原谱拓展o型口蹄疫病毒株及其构建方法和应用
CN117304277B (zh) * 2023-09-26 2024-03-08 中国农业科学院兰州兽医研究所 一种o型口蹄疫病毒vp4蛋白t细胞表位多肽及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983003547A1 (en) * 1982-04-14 1983-10-27 Bittle, James, L. Synthetic picornavirus antigen
US4769237A (en) * 1983-03-25 1988-09-06 Bittle James L Synthetic picornavirus antigen
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US5476765A (en) * 1987-01-09 1995-12-19 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV and as vaccines
GB8920357D0 (en) * 1989-09-08 1989-10-25 Wellcome Found Peptides
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
US5759551A (en) 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
CA2161445C (en) * 1993-04-27 2009-06-30 Anna Efim Ladd Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
AU8091694A (en) * 1993-10-26 1995-05-22 United Biomedical Inc. Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics

Also Published As

Publication number Publication date
AU754939B2 (en) 2002-11-28
CN1354674A (zh) 2002-06-19
BRPI9912178B1 (pt) 2017-03-28
CN101469017B (zh) 2012-11-07
CN101386641A (zh) 2009-03-18
CA2330178C (en) 2013-10-15
WO1999066954A1 (en) 1999-12-29
TWI232108B (en) 2005-05-11
EP1089759A4 (en) 2005-02-02
BR9912178A (pt) 2001-04-10
CN101353373A (zh) 2009-01-28
CN101386641B (zh) 2012-12-05
EP1089759B1 (en) 2017-02-01
CN101353373B (zh) 2013-06-19
JP2002518461A (ja) 2002-06-25
KR20010053042A (ko) 2001-06-25
AR019152A1 (es) 2001-12-26
EP1089759A1 (en) 2001-04-11
CN100435846C (zh) 2008-11-26
US6107021A (en) 2000-08-22
KR100602553B1 (ko) 2006-07-20
CA2330178A1 (en) 1999-12-29
CN101469017A (zh) 2009-07-01
AU4826699A (en) 2000-01-10

Similar Documents

Publication Publication Date Title
IL139464A0 (en) Synthetic peptide vaccines for foot-and mouth disease
IL148713A0 (en) Oral recombinant lactobacilli vaccines
PL337488A1 (en) Oil-in-water type compositions for vaccines
HUP0101437A3 (en) Oral pharmaceutical extended release dosage form
PL351486A1 (en) Prrsv vaccines
PT2275553E (pt) Péptidos antigénicos de neisseria
GB9713149D0 (en) Pharmaceutical formulations
HUP9903407A3 (en) Oral pharmaceutical preparation containing ibandronat
EP0682945A3 (de) Orale Retard-Präparation.
IL130631A0 (en) Oral cyclosporin formulations
SI1183026T1 (sl) Izboljsane farmacevtske spojine, vsebujoce ritonavir
ZA982112B (en) Rapamycin formulations for oral administration.
HUP9904345A3 (en) Oral contraceptive
GB9918156D0 (en) Synthetic peptides
GB9822714D0 (en) Vaccines
ZA979592B (en) Oral vaccine for animals
ZA985095B (en) Rapamycin formulations for oral administration.
GB9923045D0 (en) New oral formulations
IL147731A0 (en) Peptide pharmaceutical formulations
HUP9601608A2 (en) Marek`s disease vaccine
EP1201245A4 (en) FUNCTIONAL ORAL PREPARATIONS
GB9718616D0 (en) Oral vaccine
HU9802974D0 (en) Dna-vaccine for infections bursal disease
IL109519A0 (en) Vaccines for oral immunization against infecting agents
IL143100A0 (en) Contraceptive antibody vaccines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired